Destiny Wealth Partners, LLC Vertex Pharmaceuticals Inc Transaction History

Destiny Wealth Partners, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 26, 2023	SELL	$283.23 - $323.1 $34,554 - $39,418	-122 Reduced 11.9%	903 $284,000
Q4 2022 Jan 26, 2023	SELL	$285.76 - $321.48 $11,716 - $13,180	-41 Reduced 3.85%	1,025 $0
Q3 2022 Oct 25, 2022	BUY	$273.83 - $305.53 $283,961 - $316,834	1,037 Added 3575.86%	1,066 $309,000
Q2 2022 Jul 15, 2022	SELL	$234.96 - $292.55 $95,628 - $119,067	-407 Reduced 93.35%	29 $8,000
Q1 2022 Apr 21, 2022	BUY	$221.42 - $260.97 $90,117 - $106,214	407 Added 1403.45%	436 $114,000
Q3 2021 Oct 28, 2021	BUY	$181.39 - $202.99 $5,260 - $5,886	29 New	29 $5,000
Q2 2021 Jul 27, 2021	SELL	$187.49 - $221.1 $14,249 - $16,803	-76 Closed	0 $0
Q4 2020 Feb 05, 2021	BUY	$207.01 - $276.09 $15,732 - $20,982	76 New	76 $18,000

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Destiny Wealth Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Destiny Wealth Partners, LLC with notifications on news.